IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428283122/en/

“At IFF Pharma Solutions, we believe sustainability is not just a responsibility but an opportunity to innovate and inspire,” said Dr. Anne Adden, global strategic marketing director for sustainability and dietary supplements. “We are committed to creating solutions that not only meet the needs of today but also pave the way for a healthier, more sustainable future. Our team of problem-solvers and experts is redefining what it means to lead in sustainable healthcare.”

Building on over 75 years of industry expertise, IFF Pharma Solutions is ready to present its diverse portfolio of offerings. This includes METHOCEL™ — Pioneering Then, Innovating Now; ETHOCEL™ — Proven Time After Time and POLYOX™ — Versatile Across Complex and Unique Applications. Our experts will also showcase the newly introduced Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) and Avicel^® PH LN, both developed to reduce nitrosamine risks in pharmaceutical formulations.

Dr. Anne Adden will present “Sustainable by Design: The Future of Excipients” on May 13, from 2:00 to 2:45 p.m. ET, in the Riverview Ballroom, Stage 2. She will discuss how IFF Pharma Solutions incorporates sustainability at every stage of excipient manufacturing, from sourcing materials to packaging.

Visit here to learn more about IFF Pharma Solutions.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ^SM or ^® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250428283122/en/